Fund Holdings — Paradigm Biocapital Advisors LP

Total Portfolio Value:
$2.61B
Total Bought:
$593.69M
Total Sold:
$684.64M
Net Transaction:
-$90.96M
Notable People:
Dr. Senai Nmn Asefaw
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc4,177,8304,571,678+393,848$313.71M$346.81M13.27%+$33.09M
argenx SEADR(ARGX)552,120538,139-13,981$217.38M$231.42M8.86%+$14.04M
Arcellx Inc
COMMON STOCK
3,818,0953,848,095+30,000$265.55M$212.38M8.13%-$53.17M
Revolution Medicines, Inc.(RVMD)2,914,9755,259,089+2,344,114$93.95M$204.11M7.81%+$110.16M
Sarepta Therapeutics, Inc.(SRPT)1,078,346947,574-130,772$139.60M$149.72M5.73%+$10.11M
Disc Medicine, Inc.(IRON)2,389,9022,704,718+314,816$148.80M$121.90M4.67%-$26.89M
Merus N V02,019,814+2,019,814$0$119.51M4.57%+$119.51M
Crinetics Pharmaceuticals In3,124,7492,513,302-611,447$146.27M$112.57M4.31%-$33.70M
Cerevel Therapeutics Hldng I2,330,5082,330,5080$98.51M$95.29M3.65%-$3.22M
Kura Oncology, Inc.(KURA)3,135,3874,539,381+1,403,994$66.88M$93.47M3.58%+$26.59M
Ascendis Pharma A/SADR(ASND)507,952664,307+156,355$76.79M$90.60M3.47%+$13.81M
Olema Pharmaceuticals, Inc.(OLMA)7,903,6007,903,6000$89.47M$85.52M3.27%-$3.95M
Xenon Pharmaceuticals Inc.(XENE)2,484,8742,043,280-441,594$106.97M$79.67M3.05%-$27.31M
Tarsus Pharmaceuticals, Inc.(TARS)2,863,4062,435,416-427,990$104.08M$66.19M2.53%-$37.89M
Janux Therapeutics, Inc.(JANX)01,564,452+1,564,452$0$65.53M2.51%+$65.53M
Arvinas, Inc.(ARVN)2,614,9352,438,149-176,786$107.94M$64.90M2.48%-$43.04M
Legend Biotech CorporationADS(LEGN)1,982,0061,203,308-778,698$111.17M$53.29M2.04%-$57.88M
Vaxcyte, Inc.(PCVX)1,239,995627,202-612,793$84.70M$47.36M1.81%-$37.34M
Y-Mabs Therapeutics Inc2,233,6103,870,594+1,636,984$36.32M$46.76M1.79%+$10.44M
Edgewise Therapeutics, Inc.(EWTX)2,446,3732,325,449-120,924$44.62M$41.88M1.60%-$2.74M
Immatics N.V.SHS(IMTX)2,818,9083,421,965+603,057$29.63M$39.76M1.52%+$10.14M
Viridian Therapeutics, Inc.(VRDN)5,031,4202,896,349-2,135,071$88.10M$37.68M1.44%-$50.42M
Immunovant, Inc.(IMVT)799,0541,362,827+563,773$25.82M$35.98M1.38%+$10.16M
Cogent Biosciences, Inc.(COGT)03,624,342+3,624,342$0$30.55M1.17%+$30.55M
BridgeBio Pharma, Inc.(BBIO)01,089,492+1,089,492$0$27.60M1.06%+$27.60M
Cullinan Therapeutics, Inc.(CGEM)1,348,0151,542,805+194,790$22.97M$26.91M1.03%+$3.94M
Erasca, Inc.(ERAS)07,250,000+7,250,000$0$17.11M0.65%+$17.11M
COMPASS Pathways plcADS(CMPS)2,390,9882,335,926-55,062$19.89M$14.11M0.54%-$5.78M
Apogee Therapeutics Inc330,000330,0000$21.93M$12.99M0.50%-$8.94M
Verona Pharma PlcADS0721,087+721,087$0$10.43M0.40%+$10.43M
ALX Oncology Holdings Inc.(ALXO)01,575,605+1,575,605$0$9.50M0.36%+$9.50M
Perspective Therapeutics, Inc.(CATX)0919,692+919,692$0$9.17M0.35%+$9.17M
Vor Biopharma Inc.(VOR)6,457,2936,457,2930$15.30M$6.46M0.25%-$8.85M
Acrivon Therapeutics Inc0659,724+659,724$0$3.83M0.15%+$3.83M
TScan Therapeutics, Inc.(TCRX)0353,886+353,886$0$2.07M0.08%+$2.07M
Agios Pharmaceuticals, Inc.(AGIO)400,0000-400,000$11.70M$0—-$11.70M
Alpine Immune Sciences Inc2,121,1630-2,121,163$84.08M$0—-$84.08M
Autolus Therapeutics plcADS(AUTL)6,425,8030-6,425,803$41.00M$0—-$41.00M
Bicycle Therapeutics PlcADS3,246,7590-3,246,759$80.84M$0—-$80.84M
Cargo Therapeutics Inc147,9590-147,959$3.30M$0—-$3.30M
Caribou Biosciences, Inc.(CRBU)2,172,6200-2,172,620$11.17M$0—-$11.17M
Immunocore Holdings plcADS(IMCR)1,787,1760-1,787,176$116.17M$0—-$116.17M
Kyverna Therapeutics, Inc.(KYTX)50,0000-50,000$1.24M$0—-$1.24M
Zentalis Pharmaceuticals, Inc.(ZNTL)944,9170-944,917$14.89M$0—-$14.89M
Page 1 of 1
Paradigm Biocapital Advisors LP — 13F Holdings — Q2 2024 | TickerTrail